Expression of hematopoietic markers in the blastic population in BPDCN cases
| Immunophenotype . | Positive result/tested (%) . |
|---|---|
| Myeloid markers | |
| CD33 | 28/65 (43) |
| CD13 | 1/60 (1.6) |
| CD15 | 3/47 (6.4) |
| CD65 | 1/39 (2.5) |
| CD117 | 12/66 (18) |
| CD36 | 50/54 (92.5) |
| CD64 | 1/35 (2.8) |
| CD14 | 0/59 (0) |
| MPO | 0/86 (0) |
| B-lymphoid markers | |
| CD19 | 0/62 (0) |
| CD22 | 8/40 (20) |
| cCD22 | 0/35 (0) |
| cCD79a | 4/57 (7) |
| cMu | 0/19 (0) |
| Sig | 0/19 (0) |
| T-lymphoid markers | |
| CD3 | 0/86 (0) |
| cCD3 | 0/86 (0) |
| CD7 | 38/64 (59) |
| CD2 | 24/59 (40.6) |
| CD5 | 3/52 (5.7) |
| CD1 | 1/25 (4) |
| CD16 | 0/40 (0) |
| CD57 | 0/8 (0) |
| CD8 | 0/49 (0) |
| cDC markers | |
| CD11c | 0/51 (0) |
| CD1c | 5/23 (21.7) |
| CD141 | 0/23 (0) |
| Immature and other markers | |
| CD34 | 1/73 (1.3) |
| Tdt | 4/27 (14.8) |
| CD133 | 0/7 (0) |
| CD10 | 9/53 (17) |
| CD38 | 37/44 (84) |
| Immunophenotype . | Positive result/tested (%) . |
|---|---|
| Myeloid markers | |
| CD33 | 28/65 (43) |
| CD13 | 1/60 (1.6) |
| CD15 | 3/47 (6.4) |
| CD65 | 1/39 (2.5) |
| CD117 | 12/66 (18) |
| CD36 | 50/54 (92.5) |
| CD64 | 1/35 (2.8) |
| CD14 | 0/59 (0) |
| MPO | 0/86 (0) |
| B-lymphoid markers | |
| CD19 | 0/62 (0) |
| CD22 | 8/40 (20) |
| cCD22 | 0/35 (0) |
| cCD79a | 4/57 (7) |
| cMu | 0/19 (0) |
| Sig | 0/19 (0) |
| T-lymphoid markers | |
| CD3 | 0/86 (0) |
| cCD3 | 0/86 (0) |
| CD7 | 38/64 (59) |
| CD2 | 24/59 (40.6) |
| CD5 | 3/52 (5.7) |
| CD1 | 1/25 (4) |
| CD16 | 0/40 (0) |
| CD57 | 0/8 (0) |
| CD8 | 0/49 (0) |
| cDC markers | |
| CD11c | 0/51 (0) |
| CD1c | 5/23 (21.7) |
| CD141 | 0/23 (0) |
| Immature and other markers | |
| CD34 | 1/73 (1.3) |
| Tdt | 4/27 (14.8) |
| CD133 | 0/7 (0) |
| CD10 | 9/53 (17) |
| CD38 | 37/44 (84) |
c, intracytoplasmic expression; cDC, classical dendritic cell; cMu, intracytoplasmic heavy-chain μ; MPO, myeloperoxidase; Sig, surface immunoglobulin; Tdt, intranuclear terminal deoxynucleotidyl transferase.